FDA announces Class I recall of ventilators after 3 patient injuries

The U.S. Food and Drug Administration (FDA) has issued a recall on behalf of ventilator manufacturer Percussionaire after a nickel coating was found on the breathing circuits of one of its products. Nickel can react to various drugs used in conjunction with the mechanical ventilator, causing lung injury, airway spasm, anaphylaxis, and possibly death.

There have been three reported injuries associated with use of the Intrapulmonary Percussive Ventilation (IPV) Phasitron 5 breathing circuit. No one has died. However, because of the serious risks the defect poses to patient health, the recall has been given a Class I designation, reserved for the most serious type. 

What is being recalled?

Certain lots of the Percussionaire Phasitron 5 ventilators are subject to the recall. More specifically, the breathing circuits are being recalled because of the nickel coating. 

Percussionaire Phasitron 5 

Here are the recalled part/lot numbers:

  • P5-10/240329, 240412,240430, 240509, 240516, 240614, 240625 
  • P5-HC-5/240321
  • P5-UC-10/240627

Patients and providers are to cease using the devices immediately. 

Next steps

If there’s an emergency situation and recalled Phasitron 5 ventilators must be used, the FDA and Percussionaire have updated safety instructions that operators should follow:

  • Rinse with sterile water after use and allow the ventilator to air dry.
  • Only use saline as the liquid in the nebulization cup.
  • Stop use if unexpected symptoms occur.
  • Do not use the ventilator to deliver medications.
  • Do not use it for more than 2 weeks.
  • Do not use it on any patient in an inflammatory state. 

The company said all customers have received a notice of the recall with instructions on how to obtain replacements. 

The full recall notice can be found here.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”